Perceptions of LARC Among AYA With Chronic Illness
NCT05000489 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 67
Last updated 2025-04-17
Summary
The investigators aim to perform a qualitative study exploring attitudes and perceived barriers to Long Acting Reversible Contraception (LARC), both implants and IUDs, among adolescent and young adults (AYA) with chronic illness at CHLA. While the literature examining barriers to LARC uptake is growing, its focus has been on older women and women who are not living with chronic illness. There remains a significant gap in the understanding of:
1. What adolescents and young adults from ethnically diverse, economically underserved communities know about LARCs
2. If and how LARCs fit into their considerations and decision making about contraception choices
3. Perceived barriers to LARC among AYA with chronic medical conditions
4. Information, perceptions, experiences that inform choices that may be unique to AYA living with chronic conditions
Research Objectives
1. Explore the impact of the experience of living with chronic medical conditions on AYA patient attitudes toward and acceptance of LARCs
2. Identify AYA patient concerns and perceptions related to historical coercion and reproductive injustice experienced by minority communities that may reduce acceptance of LARC
3. Explore the relationship between patients' perception of pediatric subspecialty care providers' attitudes regarding sexual health and contraception guidance and patients' attitudes toward and acceptance of LARC
4. Identify factors related to patient's age, family's values, and medical condition, as well as historical events or legacies that may impact preference of implant vs intra-uterine device (IUD), independent of safety/medical contraindications, if choosing a LARC method.
5. Explore other social, cultural or psychological factors that influence perception and represent barriers to LARC access
Hypotheses
1. The impact of chronic illness on AYA sense of bodily autonomy (including self-concept, history of other medical procedures, and concerns around mortality) reduces the attractiveness of LARC methods.
2. The intersectionality of multiple oppressions, including racism, xenophobia, sexism, and historical reproductive coercion and injustice implicitly reduce the attractiveness of LARC methods for AYA patients from minority communities with chronic medical conditions at CHLA.
3. Pediatric subspecialty providers' attitudes about sex, and comfort with providing patient-centered contraception counseling, as perceived by AYA patients, impact AYA patient attitudes towards and acceptance of LARC.
4. Preference of implant vs. IUD is related to patient's age, family values, and type of medical condition, as well as their knowledge of historical events related to contraception in their community, independent of safety/medical contraindications.
5. Additional perceived barriers, including fear or skepticism about LARC conferred by trusted sources of information such as family or social media, reduce the attractiveness and acceptance of LARC by AYA with chronic medical conditions
Conditions
- Chronic Conditions, Multiple
Interventions
- OTHER
-
No intervention being administered
No intervention will be administered. Each patient will participate in a qualitative focus group discussing their beliefs/attitudes about their reproductive health and birth control
Sponsors & Collaborators
-
Organon
collaborator INDUSTRY -
Children's Hospital Los Angeles
lead OTHER
Principal Investigators
-
Claudia Borzutzky, MD · Children's Hospital Los Angeles
-
Ellen Iverson, MPH · Children's Hospital Los Angeles
Eligibility
- Min Age
- 16 Years
- Max Age
- 21 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-04-16
- Primary Completion
- 2022-04-07
- Completion
- 2022-04-07
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of an Intervention to Increase Post-abortion LARC Uptake.
NCT03214848 ·Status: COMPLETED ·Phase: NA
-
Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study
NCT00528112 ·Status: COMPLETED ·Phase: PHASE3
-
Patient Compliance With Long-Acting Reversible Contraception Administration
NCT03305081 ·Status: TERMINATED ·Phase: NA
-
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
NCT00995150 ·Status: TERMINATED ·Phase: PHASE3
-
Assessment of Cultural Acceptability of Long Acting Contraception in a Diverse, Urban Population
NCT03486743 ·Status: COMPLETED ·Phase: NA
-
A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon.
NCT03725358 ·Status: WITHDRAWN ·Phase: NA
-
Evaluation of the Impact of an Oral and Practical Presentation of Intrauterine Devices by a Health Professional on Women's Opinion as a Possible Contraceptive Method
NCT05317715 ·Status: UNKNOWN ·Phase: NA
-
Combined Hormonal Contraceptive Use in High Risk Women: A Longitudinal Study
NCT00361400 ·Status: COMPLETED
-
Innovative Model of Patient-Centered ConTraception
NCT02364037 ·Status: COMPLETED ·Phase: NA
-
Feasibility of Immediate Postpartum Long-acting Reversible Contraception Implementation
NCT03774797 ·Status: COMPLETED
-
Using Focus Group to Explore Cultural Acceptability of Contraception
NCT02945670 ·Status: COMPLETED
-
European Active Surveillance Study of LCS12
NCT02146950 ·Status: ACTIVE_NOT_RECRUITING
-
LCS12 Adolescent Study
NCT01434160 ·Status: COMPLETED ·Phase: PHASE3
-
HR-QoL and Sexuality in Mirena Inserted Contraception Users
NCT00498784 ·Status: COMPLETED ·Phase: PHASE4
-
Contraceptive Choice at the Time of Uterine Evacuation
NCT02836561 ·Status: COMPLETED ·Phase: NA
-
Ovarian Function With ENG Implant and UPA Use
NCT04291001 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
LCS12 vs. ENG Subdermal Implant (Nexplanon) Discontinuation Rate Study
NCT01397097 ·Status: COMPLETED ·Phase: PHASE3
-
Implants on Mobile Health Unit
NCT03347539 ·Status: COMPLETED
-
Oral Contraceptive Pills Compared to Vaginal Rings
NCT00357526 ·Status: COMPLETED ·Phase: NA
-
DIU-QoL. Quality of Life Evaluation in Intrauterine Device Users.
NCT01731132 ·Status: COMPLETED
-
Long-Acting Progestin Contraception and the Vaginal Microbiome
NCT02740998 ·Status: COMPLETED
-
MyNewOptions: An Online Study of Reproductive Life Planning and Contraceptive Action Planning
NCT02100124 ·Status: COMPLETED ·Phase: NA
-
Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding
NCT03642210 ·Status: COMPLETED ·Phase: PHASE3
-
Plan A Birth Control: Randomized Controlled Trial of a Mobile Health Application for Contraception Information
NCT02234271 ·Status: COMPLETED ·Phase: NA
-
Evaluation of ContraMed VeraCept Intrauterine Copper Contraceptive for Long Acting Reversible Contraception
NCT02446821 ·Status: COMPLETED ·Phase: PHASE2